Clinical Trial Update: The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the efficacy and safety of OROSARTAN versus CODIOVAN in adults with essential hypertension not controlled on monotherapy. The update r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CODIOVAN
• OROSARTAN

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Hypertension | Phase 4 | Status: COMPLETED